Cancer Risk After Organ Transplantation in Sweden
Author Information
Author(s): J Adami, H Gäbel, B Lindelöf, K Ekström, B Rydh, B Glimelius, A Ekbom, H-O Adami, F Granath
Primary Institution: Karolinska Institutet
Hypothesis
What is the cancer risk following organ transplantation?
Conclusion
The study found a four-fold overall risk of cancer following organ transplantation, particularly for nonmelanoma skin cancer, lip cancer, and non-Hodgkin's lymphoma.
Supporting Evidence
- Overall, 692 primary cancers were observed compared to 171 expected, yielding an SIR of 4.0.
- The cumulative risk of developing any malignancy was 13.6% after 10 years and 31.8% after 20 years post-transplant.
- Nonmelanoma skin cancer had a significantly high SIR of 56.2.
- Patients under 40 years at transplantation had a 2.5-fold higher cancer risk compared to those over 60.
- Men had a higher overall cancer risk compared to women following transplantation.
Takeaway
People who get organ transplants have a higher chance of getting certain types of cancer, especially skin cancer.
Methodology
The study used a large population-based cohort from Swedish health registries to analyze cancer incidence among organ transplant recipients.
Potential Biases
Potential underestimation of cancer risks due to reliance on registry data and lack of individual medical record review.
Limitations
The study relied on registry data, which may not capture all relevant medical history and lifestyle factors.
Participant Demographics
The cohort included 3592 males and 2339 females, with a median age of 46 years at transplantation.
Statistical Information
Confidence Interval
95% CI=3.7–4.4
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website